Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
March 5, 2018
US Bioservices now dispenses CABOMETYX
The U.S. Food and Drug Administration has recently approved CABOMETYX (cabozantinib) for the expanded indication of patients with previously untreated advanced renal cell carcinoma (RCC).